Siegfried Holding AG (LON:0QQO)

Market Cap	3.28B -14.4%
Revenue (ttm)	1.24B +2.6%
Net Income	158.03M +5.4%
EPS	3.60 +4.1%
Shares Out	n/a
PE Ratio	20.72
Forward PE	18.83
Dividend	0.35 (0.44%)
Ex-Dividend Date	Apr 22, 2025

Volume	1,860
Average Volume	25,128
Open	77.60
Previous Close	79.30
Day's Range	76.90 - 78.20
52-Week Range	59.10 - 101.20
Beta	0.74
RSI	36.65
Earnings Date	Feb 20, 2026

About Siegfried Holding AG

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition,...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1873
• Employees: 3,891
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QQO

Financial Performance

In 2025, Siegfried Holding AG's revenue was 1.33 billion, an increase of 2.57% compared to the previous year's 1.29 billion. Earnings were 168.66 million, an increase of 5.37%.

Financial numbers in CHF